SLN124, a GalNAc-siRNA Conjugate Targeting TMPRSS6, Efficiently Prevents Iron Overload in Hereditary Haemochromatosis Type 1

  • Hemasphere. 2019 Oct 1;3(6):e301. doi: 10.1097/HS9.0000000000000301.
Sandro Altamura  1  2 ,  Ute Schaeper  3 ,  Sibylle Dames  3 ,  Kathrin Löffler  3 ,  Mona Eisermann  3 ,  Christian Frauendorf  3 ,  Katja Müdder  1  2 ,  Joana Neves  1 ,  Martina U Muckenthaler  1  2
Affiliations
  • 1. Department of Pediatric Hematology, Oncology and Immunology - University of Heidelberg, Germany.
  • 2. Molecular Medicine Partnership Unit, Heidelberg, Germany.
  • 3. Silence Therapeutics GmbH, Berlin, Germany.
Products